Why Some Clinical Research Sites Thrive While Others Struggle

Hero image of Dan Nwosu - VP of Clinical Operations at the Clinical Trials Network

Clinical research sites don’t succeed by accident. Some thrive, consistently enrolling patients and delivering high-quality results, while others struggle to get studies off the ground. In this conversation, Dan Nwosu, Vice President of Clinical Operations at The Clinical Trial Network, shares his rare perspective from working on the ground at research sites, supporting studies from the CRO side, and now overseeing operations across the network.

Dan dives into what makes a great Principal Investigator, why strong teams and operational processes are critical, and how patient-centered execution drives long-term site success. Whether you’re a new investigator, site coordinator, or research professional, these insights reveal what truly separates high-performing clinical research sites from the rest.

How did you get started in clinical research?​

Both of my parents were actively involved on the investigatory side of research, so clinical research was something I was exposed to early on. Seeing firsthand how studies connected science to real people sparked my interest long before I ever thought about it as a career.

My path into clinical research started early and very hands-on. I earned dual degrees in biology and chemistry, and while I was still in school I was introduced to research through academic labs, first working on early childhood language acquisition and later in Alzheimer’s research. Those experiences shaped how I think about research to this day. They taught me the importance of discipline, structure, and scientific curiosity, but also how much consistency and rigor matter if you want a program to actually work.

Over time, my career expanded across almost every part of the clinical research ecosystem. I’ve worked directly at research sites, supported studies from the CRO side, and now oversee operations at the network level. Seeing the process from all of those perspectives has been invaluable. It’s allowed me to understand what truly separates successful sites from those that struggle, not just in theory, but in practice. Strong sites aren’t defined by one role or one process; they’re built by aligning science, operations, and patient-centered execution in a way that’s sustainable over time.

Throughout your career, what reinforced your decision to continue going deeper into the world of clinical research?

One of the most defining moments for me was my time at MetroHealth, working on spinal cord injury studies. That experience completely changed how I viewed the purpose of clinical research. When people hear “spinal cord injury,” they often assume success means walking again, but that’s not what most patients were focused on.

What mattered to them was independence. Being able to use their hands, return to work, take care of themselves, and re-engage in everyday life. Seeing that up close made the impact of research very real. Even small gains in motor or sensory function had a meaningful effect on how someone lived day to day.

That’s what kept pulling me deeper into research. It wasn’t about chasing abstract outcomes or distant breakthroughs. It was about helping people get pieces of their normal lives back. Research creates access, options, and hope, even when progress is incremental. Being part of that process — and building systems that make it work consistently for patients — reinforced that this is where I could make the biggest impact.

You have a very unique perspective having spent years on the site level executing studies and then also having worked for a Contract Research Organization (CRO) like IQVIA. What did that experience teach you?

Honestly, my time at IQVIA really shifted the way I think about research. When you’re at a site, you’re focused on the day-to-day — patient visits, making sure everything’s ready, that all the consents are in place. That’s important, but it’s a very narrow view. Moving into the CRO world, I had to start thinking about the bigger picture — how do we make this study succeed across multiple sites? What are the barriers keeping enrollment from happening? Are the PIs fully supported? Do their teams have the right tools, the right training?

It really made me see the difference between doing research and enabling research to succeed. Even though I wasn’t in the room with patients every day anymore, everything I was doing was still centered on them. Strong operational processes, proactive support, clear communication — all of that ultimately makes it easier for sites to recruit, retain, and care for patients. Seeing research from both sides — boots on the ground and systems-level operations — gave me a perspective that not many people get, and it really reinforced for me what separates high-performing sites from ones that struggle.

What separates high-performing sites from ones that struggle?

Honestly, it comes down to the team more than anything else. I think a lot of people focus on the PI, but the truth is a great Principal Investigator is only as strong as the staff supporting them. The most successful sites I’ve seen have incredible coordinators, nurses, and research staff who really understand the mission and keep everything moving.

PIs already have so much on their plate — clinical responsibilities, patient care, administrative tasks. Having a team that can take a project and run with it, keep the PI accountable, and make sure all the details are in order is what separates a high-performing site from one that struggles. It’s like a film set — you can have a director with a great vision, but if your crew isn’t solid, the whole project can fall apart.

Beyond staffing, it’s also about processes. High-performing sites know how to manage workflow, handle regulatory requirements, keep communication clear, and anticipate barriers before they become problems. They’re proactive, not reactive. And most importantly, everything they do is patient-centered — whether it’s recruitment, retention, or day-to-day study execution, the patient experience drives how the site operates.

At the end of the day, strong people plus strong processes equals strong sites. If either piece is missing, you’re going to struggle. It’s that simple, and it’s why investing in your team and your operations is non-negotiable if you want sustainable success.

What advice do you have for physicians who are new to clinical research?​

If you’re a physician who’s new to research, the biggest thing I’d say is: know what you don’t know. You’ve got to be willing to lean on the people around you — your site staff, your research coordinators, and teams like ours at CTNx who are here to support you every step of the way. Strong leadership isn’t about knowing everything; it starts with good followership. You learn by watching, asking questions, and trusting the expertise of the people who’ve been there before you.

Don’t be afraid to make mistakes, either. Clinical research is a learning environment, and it’s supposed to be. The more questions you ask, the more you engage, and the more open you are to feedback, the stronger your site and your program will become. It’s all about building the right team, learning together, and keeping patient care at the center of everything you do.

Can you share a little bit about how your operations teams at CTNx support sites that join the network?​

At CTNx, our operations model is really built around supporting sites at every stage, from day one through full study execution. We’ve structured our teams so that no site feels like they’re figuring it out alone.

Our Research Integrity team, led by Whitney Heath, makes sure sites stay on top of regulatory compliance, audit readiness, and proper study conduct. They’re the go-to resource for questions on submissions, monitoring, or just making sure everything is being done correctly. We’re proud of our Compliance team, whose meticulous approach ensures every “i” is dotted and every “t” is crossed—resulting in zero non-compliance letters across our 85+ sites.

Then there’s Data Operations, led by Seth Brine. Their focus is on data quality and accuracy before anything even reaches the EDC. They clean the data, review entries, and help sites avoid common pitfalls. That proactive approach reduces errors down the line and makes reporting and analysis smoother.

Finally, our Site Engagement team, led by Kevin Ignasiak, is the first point of contact for new sites. They guide sites through onboarding, make sure staffing is in place, confirm documentation is complete, and help set operational workflows. Essentially, they make sure a site is ready to hit the ground running before studies even start.

When all three teams are working together, sites get more than support — they get a framework that helps them run efficiently, focus on patients, and ultimately succeed. That’s really what separates high-performing sites from the rest: people who are prepared, supported, and aligned around the same goals.

Together, these teams remove friction, reduce risk, and help sites focus on what matters most: enrolling and caring for patients.

What makes CTNx different, and what’s your parting message for sites considering joining the network?

Honestly, what sets CTNx apart is that we treat every site like a partner, not just a location on a list. We’re not here to just hand you a protocol and walk away. We’re in it with you — helping you build the systems, staff, and processes that actually make your studies succeed. That partnership is what drives strong site performance and ultimately better outcomes for patients.

My message to any site thinking about joining CTNx is simple: be ready to engage, and you’ll get just as much back. Research isn’t just about funding or getting a study done — it’s about learning, growing, and making a real impact for patients. If you’re willing to invest in the process, ask questions, and work with a team that’s here to support you every step of the way, you’ll see results. Sites that succeed aren’t perfect from day one — they succeed because they have the right people, the right support, and the right systems in place. That’s what makes sites high-performing, and that’s exactly what we aim to deliver at CTNx.

The Clinical Trials Network (CTNx) Partners with SelectIQ to Revolutionize Patient Recruitment for Clinical Research Sites

The Clinical Trials Network (CTNx) Partners with SelectIQ to Revolutionize Patient Recruitment for Clinical Research Sites

 

The Clinical Trials Network (CTNx) has forged a strategic partnership with SelectIQ to transform patient recruitment for clinical research sites. SelectIQ offers an innovative software that seamlessly integrates with a practice’s Electronic Medical Records (EMR) system, harnessing the power of artificial intelligence to analyze patient records. This technology flags individuals whose medical history aligns with the criteria for participation in a clinical trial, ranking them based on their likelihood of participation.

CTNx enhances this process by providing additional support to research sites. Their team conducts outreach, calling and pre-screening potential study candidates to ensure they meet the necessary qualifications. Utilizing an Institutional Review Board (IRB) approved script, qualified candidates are identified and referred to the research site’s study coordinator for an in-person screening and study enrollment.

Christopher Petek, Chief Operating Officer of The Clinical Trials Network, expressed enthusiasm about the partnership, stating, “Patient enrollment is paramount to the success of any study and research site. We are excited to leverage this cutting-edge technology to empower our research sites, streamlining the identification and enrollment of qualified patients in clinical trials.”

Ethan Bond, Chief Executive Officer of SelectIQ, shared that “SelectIQ empowers healthcare providers to connect their patients with relevant clinical trial opportunities. CTNx is a natural collaborator given their success bringing trials into community healthcare practices. We’re proud to support their important work.”

Research sites keen on optimizing their clinical trial enrollment processes can learn more about CTNx’s offerings by visiting their website at www.thectnx.com or requesting to schedule a live demo through the following online form

 

About CTNx

The Clinical Trials Network (CTNx) is a network of private practice research sites committed to enhancing access and diversity in clinical trials. Since its establishment in 2018, CTNx has facilitated the opening of over 90 research sites spanning various medical specialties, including Gastroenterology, Ophthalmology, Dermatology, Allergy/Immunology, Pulmonology, Neurology/Psychiatry, Cardiology, Rheumatology, Endocrinology, and Women’s Health.

CTNx is renowned for its comprehensive centralized administrative support and its in-house program for identifying and training clinical research coordinators, assisting both novice and seasoned investigators in navigating the clinical trial landscape. For more information, visit www.thectnx.com.

About SelectIQ

SelectIQ is a Provider Activation Platform that reduces burden on healthcare providers who wish to make clinical trial opportunities available to their patients. Founded by industry veterans from data and AI firm Palantir, SelectIQ brings a wealth of expertise in clinical data analytics, security, and governance.

The team has a proven track record of developing robust software solutions for esteemed organizations, including intelligence agencies, academic medical centers, and leading pharmaceutical companies. Notably, SelectIQ’s founders played instrumental roles in crafting the data governance systems safeguarding clinical data within the National Institutes of Health’s COVID research platform and the United Kingdom’s National Health Service (NHS). For more information, visit www.selectiq.com.

Interested in SelectIQ and working with us ? Contact us today!

The Clinical Trials Network (CTNx) Adopts VersaTrial to Alleviate Tech Overload and Empower Research Teams

image with Christopher Petek the Clinical Trials Newtwork president. Banner with quote. Blue and white.

The Clinical Trials Network (CTNx) Adopts VersaTrial to Alleviate Tech Overload and Empower Research Teams

VersaTrial, the clinical research site enablement and engagement platform, today announced a collaboration with The Clinical Trials Network (CTNx). CTNx has chosen to adopt VersaTrial’s Study Organizer, aiming to elevate research productivity and efficiency across its expansive network of over 75 specialty-based private practice research sites.

VersaTrial will provide CTNx’s research staff with a streamlined solution to consolidate and access important study information such as technology portals, login credentials, and external contacts for each clinical trial. Its intelligent internet browser extension will enable users to quickly reference study-specific information directly and seamlessly within other clinical  technologies like EDC, CTMS, and ePRO systems. 

CTNx will be joining a rapidly expanding global community of research sites, hospitals, and academic medical centers who report increased productivity, reduced frustration, and greater job satisfaction thanks to VersaTrial.

“VersaTrial was specifically designed to reduce the technological burdens often associated with clinical research,” said Mike Wenger, founder and CEO of VersaTrial. “We fully support CTNx’s vision to simplify and make clinical research more accessible for private practices. I’m delighted that our solution can provide CTNx study teams the much-needed extra time to concentrate on accuracy, adherence to protocols, and most importantly, patient care.”

Christopher Petek, President of CTNx, echoed this sentiment: “We’re thrilled about our new partnership with VersaTrial and look forward to rolling out their study organizer to all the research sites in The Clinical Trials Network (CTNx). At CTNx we’re constantly looking for ways to make the lives of clinical research coordinators and investigators easier. VersaTrial does exactly that, helping organize study information which saves time and improves site staff productivity.”

“At CTNx we’re constantly looking for ways to make the lives of clinical research coordinators and investigators easier. VersaTrial does exactly that, helping organize study information which saves time and improves site staff productivity.”


The Clinical Trials Network currently boasts 75 network sites, over 11,000 enrolled patients, partnerships with more than 60 sponsors, and over 400 clinical trials. Their focus areas include Gastroenterology, Ophthalmology, Dermatology, Allergy/Immunology, Neurology, and Women’s Health. 

About CTNx

The Clinical Trials Network (CTNx) is a specialty-based network of private practice research sites dedicated to expanding access and representation in clinical trials. Since its inception in 2018, CTNx has opened over 75 sites with networks in Gastroenterology, Ophthalmology, Dermatology, Allergy/Immunology, Neurology, and Women’s Health. CTNx has built its reputation on assisting naïve investigators through the clinical trial space with its fully integrated centralized administrative support and in-house clinical research coordinator identification and training program. For more information, visit www.thectnx.com.

About VersaTrial

VersaTrial is the all-in-one site portal that lets Sponsors and CROs improve clinical trial speed, quality, and collaboration. Enabling sites to spend more time with patients and less time navigating technology systems unlocks faster trials with fewer mistakes, wider tech adoption, and stronger site relationships. Only VersaTrial’s clinical trial site engagement platform provides Sponsors and CROs with real-time operational insights, bi-directional communication, and access management alerts to ensure measurable partner oversight and quality execution. Learn more at https://www.versatrial.io.